Sep. 25, 2025 at 4:03 PM ET6 min read

Centrus Energy Corp.: A Stock to Watch Amid Promising Deals?

Tim BohenAvatar
Written by Tim Bohen
Reviewed by Ben Sturgill Fact-checked by Ellis Hobbs

Centrus Energy Corp.’s stock has been trading up by 13.77 percent, driven by positive market sentiment.

Recent Developments

  • A Memorandum of Understanding (MOU) between Centrus Energy and Korea Hydro & Nuclear Power and POSCO International is paving the way for potential investment to expand the uranium enrichment plant in Ohio. While this isn’t a binding contract, it reflects strong confidence in Centrus and its technology for uranium enrichment.
  • The growing interest in nuclear energy and uranium markets has Centrus Energy stepping up its game. The company plans to engage in several investor meetings and conferences in major financial hubs like London and New York.

  • Strategic partnerships are bolstering Centrus Energy stock. A notable alliance involves increasing the supply volume of low-enriched uranium for KHNP and POSCO International. This positions the company well against global competitors.

Candlestick Chart

Live Update At 16:02:52 EST: On Thursday, September 25, 2025 Centrus Energy Corp. stock [NYSE American: LEU] is trending up by 13.77%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Earnings and Financial Overview

When it comes to trading, having a well-thought-out strategy is essential. Traders often rely on comprehensive analysis and data to make informed decisions before entering any trade. At times, the allure of quick profits can tempt traders to act on insufficient analysis. As Tim Bohen, lead trainer with StocksToTrade, says, “If you’re still guessing at the end of your analysis, it’s probably not a trade worth taking.” This highlights the importance of ensuring your due diligence is thorough. Without a clear strategy and understanding of market conditions, trading becomes more a game of chance rather than skill. Thus, it is crucial for traders to assess their preparedness and confidence in their analysis before proceeding with a trade.

In recent times, Centrus Energy has seen both challenges and gains. Despite a Q2 revenue dip, the company’s year-to-date stock price is up by 202%. This is quite the increase when we consider the pressures in the uranium market. Analyzing the daily stock activity, fluctuating prices have become more favorable, reaching a close high of $312.19 on Sep 25, 2025.

Taking a broader look, Centrus’s ebitda margin is at 30.6%, and with an impressive gross margin of 36.1%, the company sustains strong profitability. This is notable particularly because it sets them apart in the competitive uranium world. Despite a lofty price-to-earnings ratio of 49.71, the company’s high demand and strategic importance make it an enticing choice for investors.

Financial reports paint a mixed picture. For the second quarter of 2025, Centrus achieved operating revenue of $154.5M, but with total expenses reaching $121M. More positively, net income from continuing operations topped at $28.9M, supported by an operating income of $33.5M. Cash flow was strong with operating cash flows at $52.8M and a significant change in working capital amounting to $104.5M.

More Breaking News

Yet, the debt scene is crucial here. Centrus’s total liabilities are $955.7M with long-term debt comprising $390M of it. Although their debt-to-equity ratio stands at 1.2, it showcases financial leverage yet managed under control with a quick ratio of 1.8.

Market Impact and News Analysis

Centrus Energy’s recent partnerships are arguably the most crucial right now. The nonbinding agreement with Korea Hydro & Nuclear Power and POSCO International reflects a strategic intention to expand the Piketon, Ohio plant. The buzz around this expansion and increased uranium supply could position Centrus favorably against rivals. This MOU encourages shared capital and innovation, a potentially game-changing move if it comes through.

Further bolstering the stock’s appeal, participation in investor events is a significant stepping stone. These events are key platforms for Centrus to highlight its roles in nuclear innovation and uranium investments. Networking here could translate to future lucrative partnerships and ventures outside of domestic borders. With a strategy centered around nuclear and uranium, the future seems robust.

Looking at the bigger financial picture, Centrus’s stock has risen 202% year-to-date, outshining several industry peers and broader indexes. Market optimism is largely anchored by the company’s hold in the High-Assay, Low-Enriched Uranium market. The backlog extending to 2040 underpins long-term profit opportunities. However, despite these positive moves, high debt and a lower Q2 revenue remain areas requiring watchful eyes.

Conclusion

Centrus Energy, with its recent strategic moves and financial gains, has understandably captured market attention. The memorandum and upcoming investor engagements spotlight Centrus’s commitment to growth and market dominance. The share price uptrend noted in recent trading sessions drives the optimism further, echoing a sentiment often seen in trading. As Tim Bohen, lead trainer with StocksToTrade says, “There’s a pattern in everything; you just have to stick around long enough to see it.” However, the weight of high debt and if upcoming projects will materialize remain essential focuses for potential traders. For those gauging long-term prospects, uncovering strategic partnerships that reduce debt impact and boost revenue will be pivotal in defining Centrus’s course forward. Only time will tell if Centrus can leverage its strengths and alliances into durable success.

This is stock news, not investment advice. StocksToTrade News delivers real-time stock market updates tailored to highlight the key catalysts driving short-term price movements. Our coverage is designed for active traders and investors who thrive in fast-moving markets, with a focus on volatile sectors like penny stocks, AI stocks, Robinhood stocks and other momentum plays. From earnings reports and FDA approvals to mergers, new contracts, and unusual trading volume, we break down the events that can spark significant price action.

Looking to level up your trading game? Explore StocksToTrade, the ultimate platform for traders. With powerful tools designed for swing and day trading, integrated news scanning, and even social media monitoring, StocksToTrade keeps you one step ahead.

Check out our quick startup guide for new traders!

Ready to build your watchlists? Check out these curated lists:

Once your watchlist is set, take the next step and trade with confidence using StocksToTrade’s robust platform. Don’t miss out — grab your 14-day trial for just $7 and experience the edge you need to thrive in today’s fast-paced markets.